Abstract:Objective To explore the significance and potential regulatory mechanisms of inhibiting the expression of calcium-binding protein S100A4 in sepsis-related lung injury.Methods Sepsis mouse models were established, and some mice were pretreated with niclosamide. Bronchoalveolar lavage fluid and lung tissue were collected. The BCA protein quantification method was used to detect the total protein concentration in mouse bronchoalveolar lavage fluid. ELISA was used to measure lung S100A4 protein levels. Hematoxylin-eosin staining was performed to evaluate pulmonary inflammation. Immunohistochemistry was used to detect the expression of lung S100A4 protein and tight junction protein Occludin. Western blotting was performed to detect the expression of potential signaling molecules.Results Compared with the Con group, the total protein concentration in the bronchoalveolar lavage fluid of mice in the LPS group increased (P < 0.05). There was no statistically significant difference in lung S100A4 levels compared to the Con group (P > 0.05). Immunohistochemical staining showed that bronchial epithelial cells in the lungs of mice in the LPS group had high expression of S100A4, and S100A4 expression was higher in the LPS group than in the Con group (P < 0.05), while Occludin expression was lower in the LPS group than in the Con group (P < 0.05). Western blotting showed that the expression of STAT3 and MAPK3 in the LPS group was higher than that in the Con group (P < 0.05). Compared with the LPS group, niclosamide pretreatment effectively reduced the expression of S100A4 in bronchial epithelial cells of mice (P < 0.05), to some extent restored Occludin expression, and downregulated the expression of STAT3 and MAPK3.Conclusion Niclosamide may downregulate S100A4 and upregulate Occludin expression through the STAT3 and MAPK3 signaling pathways, thereby alleviating sepsis-related lung injury.